Adiuvo Investments S.A. (ADV.WA)
PLN 1.06
(-3.2%)
PLN 1.06
(-3.2%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -10.84 Million PLN | 80.72% |
| 2022 | -57.89 Million PLN | -226.16% |
| 2021 | -17.75 Million PLN | -5.84% |
| 2020 | -16.77 Million PLN | 2.56% |
| 2019 | -17.21 Million PLN | 36.74% |
| 2018 | -27.2 Million PLN | 48.24% |
| 2017 | -52.56 Million PLN | -205.66% |
| 2016 | -17.19 Million PLN | 4.28% |
| 2015 | -17.96 Million PLN | -1142.6% |
| 2014 | 1.72 Million PLN | 154.81% |
| 2013 | -3.14 Million PLN | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | 1.98 Million PLN | 283.01% |
| 2024 Q1 | -1.08 Million PLN | 83.2% |
| 2023 Q3 | -983 Thousand PLN | 67.45% |
| 2023 Q4 | -6.44 Million PLN | -555.95% |
| 2023 FY | -11.16 Million PLN | 80.72% |
| 2023 Q1 | -848 Thousand PLN | 98.15% |
| 2023 Q2 | -3.02 Million PLN | -256.13% |
| 2022 Q2 | -3.6 Million PLN | -405.19% |
| 2022 Q4 | -45.75 Million PLN | -484.48% |
| 2022 Q3 | -7.82 Million PLN | -117.32% |
| 2022 Q1 | -713 Thousand PLN | -148.87% |
| 2022 FY | -57.89 Million PLN | -226.16% |
| 2021 FY | -17.75 Million PLN | -5.84% |
| 2021 Q3 | -4.58 Million PLN | 65.76% |
| 2021 Q4 | 1.45 Million PLN | 131.84% |
| 2021 Q1 | -1.03 Million PLN | 84.64% |
| 2021 Q2 | -13.38 Million PLN | -1191.7% |
| 2020 Q2 | -841 Thousand PLN | 73.78% |
| 2020 Q3 | -2.21 Million PLN | -163.26% |
| 2020 FY | -16.77 Million PLN | 2.56% |
| 2020 Q1 | -3.2 Million PLN | 26.91% |
| 2020 Q4 | -6.74 Million PLN | -204.7% |
| 2019 Q1 | 266 Thousand PLN | 102.54% |
| 2019 FY | -17.21 Million PLN | 36.74% |
| 2019 Q4 | -4.38 Million PLN | -118.25% |
| 2019 Q3 | -2.01 Million PLN | 68.63% |
| 2019 Q2 | -6.41 Million PLN | -2509.77% |
| 2018 Q4 | -10.47 Million PLN | -123.16% |
| 2018 FY | -27.2 Million PLN | 48.24% |
| 2018 Q2 | -6.57 Million PLN | -17.2% |
| 2018 Q1 | -5.6 Million PLN | 76.45% |
| 2018 Q3 | -4.69 Million PLN | 28.55% |
| 2017 Q4 | -23.8 Million PLN | -262.34% |
| 2017 Q1 | -4.2 Million PLN | 10.15% |
| 2017 FY | -52.56 Million PLN | -205.66% |
| 2017 Q3 | -6.57 Million PLN | -18.81% |
| 2017 Q2 | -5.53 Million PLN | -31.57% |
| 2016 Q2 | -5.01 Million PLN | -57.35% |
| 2016 Q4 | -4.67 Million PLN | -8.51% |
| 2016 FY | -17.19 Million PLN | 4.28% |
| 2016 Q3 | -4.31 Million PLN | 14.09% |
| 2016 Q1 | -3.18 Million PLN | 43.84% |
| 2015 Q4 | -5.67 Million PLN | -63.35% |
| 2015 Q3 | -3.47 Million PLN | -13.82% |
| 2015 FY | -17.96 Million PLN | -1142.6% |
| 2015 Q2 | -3.05 Million PLN | 50.07% |
| 2015 Q1 | -6.11 Million PLN | -75.62% |
| 2014 Q1 | -3.44 Million PLN | 3.12% |
| 2014 Q2 | -2.1 Million PLN | 39.0% |
| 2014 Q3 | 10.75 Million PLN | 611.71% |
| 2014 Q4 | -3.48 Million PLN | -132.4% |
| 2014 FY | 1.72 Million PLN | 154.81% |
| 2013 FY | -3.14 Million PLN | 0.0% |
| 2013 Q4 | -3.55 Million PLN | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Genomtec S.A. | -9.01 Million PLN | -20.271% |
| Medinice S.A. | -5.07 Million PLN | -113.722% |
| Medicalgorithmics S.A. | -578 Thousand PLN | -1775.433% |
| Synektik Spólka Akcyjna | 84.63 Million PLN | 112.808% |